Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Cesarean Section
NCT07078942Phase 4Not yet recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postpartum hemorrhage (PPH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Perioperative Blood Loss. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT07078942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07078942.